Yamo Pharmaceuticals

0 followers

‌

Yamo Pharmaceuticals is a clinical-stage pharmaceutical company that develops L1-79, a novel therapy for Autism spectrum disorder.

Industries

Headquarters

Employees

Links

Org chart

Chief Executive Officer

Chuck Bramlage

Collapse

Chief Financial Officer

Senior Vice President – Regulatory Affairs & Quality

Vice President Of Clinical Research Operations

AbbVie

149 followers

Amgen

181 followers

Bristol-Myers Squibb

163 followers

Ionis Pharmaceuticals

22 followers

Syneos Health

16 followers

Abbott

264 followers

Cytokinetics

11 followers

Avantor

10 followers

Charles River Laboratories

9 followers

Schrödinger

8 followers

ADARx Pharmaceuticals

2 followers

Discover companies